GWAS |
- Breast cancer ( 29059683 23535729)
- Cellular nuclear factor (erythroid-derived 2)-like 2 levels ( 30767168)
- Cognitive decline rate in late mild cognitive impairment ( 26252872)
- Estimated glomerular filtration rate ( 31152163)
- Heel bone mineral density ( 30598549)
- Metabolite levels ( 23823483)
- Migraine ( 22683712 27322543)
- Migraine - clinic-based ( 23793025)
- Night sleep phenotypes ( 27126917)
- Postprandial triglyceride response ( 32603185)
- Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab) ( 25117820)
- Systolic blood pressure ( 30224653)
- Tonometry ( 17903302)
|
- Accelerometer-based physical activity measurement (fraction of time with accelerations >425 milli-gravities) ( 29899525)
- Appendicular lean mass ( 33097823)
- Birth weight ( 31043758)
- Height ( 28552196 20881960 25282103)
- Hip circumference adjusted for BMI ( 34021172)
- Insomnia symptoms (never/rarely vs. sometimes/usually) ( 30804566)
- Insomnia symptoms (never/rarely vs. usually) ( 30804566)
- Myopia (pathological) ( 23049088)
- Paget's disease ( 21623375)
- Physical activity (overall physical activity time) ( 30531941)
- White blood cell count ( 32888494)
|